NF-κB: The inducible factors of HIV-1 transcription and their inhibitors

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 1, 2009, Pages 60-69

  Mingyan, Yu ^a   Xinyong, Liu ^a   De Clercq, Erik ^b  

^a SHANDONG UNIVERSITY   (China)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

AIDS; HIV 1; I B; IKK; Inhibitor; LTR; NF B; Transcription

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 AMINO 6 [2 (CYCLOPROPYLMETHOXY) 6 HYDROXYPHENYL] 4 (PIPERIDIN 4 YL)NICOTINONITRILE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; BENZIMIDAZOLE DERIVATIVE; BUTYLATED HYDROXYANISOLE; EVANS BLUE; I KAPPA B; I KAPPA B KINASE; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOINDOLE DERIVATIVE; ISOMESUOL; JPL 32; LIGNIN; MESUOL; N ARACHIDONOYLDOPAMINE; NORADRENALIN; OLTIPRAZ; PENTOXIFYLLINE; PERTUSSIS TOXIN; PHTHALIDE DERIVATIVE; PROSTAGLANDIN A1; PROTEIN KINASE C INHIBITOR; PYRROLIDINE DITHIOCARBAMATE; STILBENE DERIVATIVE; THIOCTIC ACID; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; TRANSCRIPTION FACTOR;

ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; DRUG STRUCTURE; DRUG TARGETING; ENZYME PHOSPHORYLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INHIBITION KINETICS; LONG TERMINAL REPEAT; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION; VIRUS INHIBITION; VIRUS TRANSCRIPTION; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

ANTI-HIV AGENTS; HIV INFECTIONS; HIV-1; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 62749127941     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709787001677     Document Type: Review

References (51)

1. Pereira, C.F.; Paridaen, J.T. Anti-HIV drug development - an overview. Curr. Pharm. Des., 2004, 10, 4005-37.
2. Cullen BR. Regulation of HIV-1 gene expression. FASEB J., 1991, 5, 2361-8.
3. Pande, V.; Ramos, M.J. Nuclear factor kappa B: a potential target for anti-HIV chemotherapy. Curr. Med. Chem., 2003, 10, 1603-15.
4. Pande, V.; Ramos, M. J. NF-kappaB in human disease: current inhibitors and prospects for de novo structure based design of inhibitors. Curr. Med. Chem., 2005, 12, 357-74.
5. Carmody, R.J.; Chen, Y.H. Nuclear factor-κB: activation and regulation during toll-like receptor signaling, Cell Mol. Immunol., 2007, 4, 31-41.
6. Schmitz, M.L.; Mattioli, I.; Buss, H.; Kracht, M. NF-kappaB: a multifaceted transcription factor regulated at several levels. Chembiochem., 2004, 5, 1348-58
7. Liang, Y.; Zhou, Y.; Shen, P. NF-kappaB and its regulation on the immune system. Cell Mol. Immunol., 2004, 1, 343-50.
8. Hayden, M.S.; Ghosh, S. Signaling to NF-κB. Genes Dev., 2004, 18, 2195-224.
9. Tian B, Brasier AR. Identification of a nuclear factor kappa B-dependent gene network. Recent Prog. Horm. Res., 2003, 58, 95-130.
10. Krappmann, D.; Scheidereit, C. A pervasive role of ubiquitin conjugation in activation and termination of IkappaB kinase pathways. EMBO Rep., 2005, 6, 321-6.
11. Ghosh, S.; Karin, M. Missing pieces in the NF-κB puzzle. Cell, 2002, 109 Suppl, S81-96.
12. Sebban, H.; Courtois, G. NF-kappaB and inflammation in genetic disease. Biochem. Pharmacol., 2006, 72, 1153-60.
13. Clifton, D.R.; Rydkina, E.; Freeman, R.S.; Sahni, S.K. NF-kappaB activation during Rickettsia rickettsii infection of endothelial cells involves the activation of catalytic IkappaB kinases IKKalpha and IKKbeta and phosphorylation-proteolysis of the inhibitor protein IkappaBalpha.. Infect. Immun., 2005, 73, 155-65.
14. Schulze-Luehrmann, J.; Ghosh, S. Antigen-receptor signaling to nuclear factor kappa B. Immunity, 2006, 25, 701-15.
15. Agou, F.; Ye, F.; Goffinont, S.; Courtois, G.; Yamaoka, S.; Israël, A.; Véron, M. NEMO trimerizes through its coiled-coil C-terminal domain. J. Biol. Chem., 2002, 277, 17464-75.
16. Puca A, Fiume G, Palmieri C, Trimboli F, Olimpico F, Scala G, Quinto I. IkappaB-alpha represses the transcriptional activity of the HIV-1 Tat transactivator by promoting its nuclear export. J. Biol. Chem., 2007, 282, 37146-57.
17. Pereira, L.A.; Bentley, K.; Peeters, A.; Churchill, M.J.; Deacon, N.J. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res., 2000, 28, 663-8.
18. West, M.J.; Lowe, A.D.; Karn, J. Activation of human immunodeficiency virus transcription in T cells revisited: NF-kappaB p65 stimulates transcriptional elongation. J. Virol., 2001, 75, 8524-37.
19. Demarchi, F.; d'Adda di Fagagna, F.; Falaschi, A.; Giacca, M. Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1. J. Virol., 1996, 70, 4427-37.
20. Bren, G.D.; Whitman, J.; Cummins, N.; Shepard, B.; Rizza, S.A.; Trushin, S.A.; Badley, A.D. Infected cell killing by HIV-1 protease promotes NF-κB dependent HIV-1 replication. PLoS ONE., 2008, 3, e2112.
21. Courtois G. The NF-kappaB signaling pathway in human genetic diseases. Cell Mol. Life Sci., 2005, 62, 1682-91.
22. Luo JL, Kamata H, Karin M. IKK/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy. J.Clin. Invest., 2005, 115, 2625-32.
23. Chen, Z.J. Ubiquitin Signaling in the NF-κB Pathway. Nat. Cell Biol., 2005, 7, 758-65.
24. Baba, M. Recent status of HIV-1 gene expression inhibitors. Antiviral Res., 2006, 71, 301-6.
25. Carnegie, G.K.; Scott, J.D. A-kinase anchoring proteins and neuronal signaling mechanisms. Genes Dev., 2003, 17, 1557-68.
26. Okazaki, T.; Sakon, S.; Sasazuki, T.; Sakurai, H.; Doi, T.; Yagita, H.; Okumura, K.; Nakano, H. Phosphorylation of serine 276 is essential for p65 NF-kappaB subunit-dependent cellular responses. Biochem. Biophys. Res. Commun., 2003, 300, 807-12.
27. Birbach A, Gold P, Binder BR, Hofer E, de Martin R, Schmid JA. Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus. J. Biol. Chem., 2002, 277, 842-51.
28. Zhong, H.; May, M.J.; Jimi, E.; Zhong, H.; May, M.J.; Jimi, E.; Ghosh, S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell, 2002, 9, 625-36.
29. Gao, N.;Asamitsu, K.; Hibi, Y.; Ueno,T.;Okamoto,T. AKIP1enhances NF-kappaB-dependentgene expression by promoting the nuclear retention and phosphorylation of p65. J. Biol. Chem., 2008, 283, 7834-43.
30. Williams, S.A.; Chen, L.F.; Kwon, H.; Ruiz-Jarabo, C.M.; Verdin, E.; Greene, W.C. NF-κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J., 2006, 25, 139-49.
31. Stevens, M.; De Clercq, E.; Balzarini, J. The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention. Med. Res. Rev., 2006, 26, 595-625.
32. Coiras, M.; López-Huertas, M.R.; Rullas, J.; Mittelbrunn, M.; Alcamí, J. Basal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression. Retrovirology, 2007, 4, 56-68.
33. Mollace V, Nottet HS, Clayette P, Turco MC, Muscoli C, Salvemini D, Perno CF. Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci., 2001, 24, 411-6.
34. Lee, R.; Beauparlant, P.; Elford, H.; Ponka, P.; Hiscott, J. Selective Inhibition of IκBα Phosphorylation and HIV-1 LTR-Directed Gene Expression by Novel Antioxidant Compounds. Virology, 1997, 234, 277-90.
35. Biswas, D. K., C. M. Ahlers, B. J. Dezube, and A. B. Pardee. Pentoxifylline and other protein kinase C inhibitors down regulate HIV-LTR NF-κB induced gene expression. Mol. Med., 1994, 1, 31-43.
36. Qatsha, K.A.; Rudolph, C.; Marmé, D.; Schächtele, C.; May, W.S. Gö 6976 a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/ low-level-producing reservoir cells in vitro. Proc. Natl. Acad. Sci. USA, 1993, 90, 4674-8.
37. Biswas, D.K.; Ahlers, C.M.;Dezube, B.J.; Pardee, A.B. Pentoxifylline and other protein kinase C inhibitorsdown-regulate HIV-LTR NF-kappa B induced gene expression. Mol. Med., 1994, 1, 31-43.
38. Mhashilkar, A.M.; Biswas, D.K.; LaVecchio, J.; Pardee, A.B.; Marasco, W.A. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists. J. Virol., 1997, 71, 6486-94.
39. Victoriano, A.F.; Asamitsu, K.; Hibi, Y.; Imai, K.; Barzaga, N.G.; Okamoto, T. Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor. Antimicrob. Agents Chemother., 2006, 50, 547-55.
40. Amici, C.; Belardo, G.; Rozera, C.; Bernasconi, D.; Santoro, M.G. Inhibition of herpesvirus-induced HIV-1 replication by cyclopentenone prostaglandins:role of IkappaB kinase (IKK). AIDS, 2004, 18, 1271-80.
41. Moriuchi, M.; Yoshimine, H.; Oishi, K.; Moriuchi, H. Norepinephrine inhibits human immunodeficiency virus type-1 infection through the NF-kappaB inactivation. Virology, 2006 345, 167-73.
42. Kwon, H.; Pelletier, N.; DeLuca, C.; Genin, P.; Cisternas, S.; Lin, R.; Wainberg, M.A.; Hiscott, J. Inducible Expression of IkBα Repressor Mutants Interferes with NF-κB Activity and HIV-1 Replicationin Jurkat T Cells. J. Biol. Chem., 1998, 273, 7431-40.
43. Sharma, R.K.; Otsuka, M. Pande, V.; Inoue, J.; Joao Ramos, M. Evans Blue is an inhibitor of nuclear factor-kappaB (NF-kappaB) - DNA binding. Bioorg. Med. Chem. Lett., 2004, 14, 6123-7.
44. Stevens, M.; Pannecouque, C.; De Clercq, E.; Balzarini, J. Pyridine N-oxide derivatives inhibit viral transactivation by interfering with NF-kappaB binding. Biochem. Pharmacol., 2006, 71, 1122-35.
45. Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell, 1998, 1, 661-71.
46. Iordanskiy, S.; Iordanskaya, T.; Quivy, V.; Van Lint, C.; Burkrinsky, M. B-oligomer of pertussis toxin inhibits HIV-1 LTR-driven transcription through suppression of NF-kappaB p65 subunit activity. Virology, 2002, 302, 195-206.
47. Márquez, N.; Sancho, R.; Bedoya, L.M.; Alcamí, J.; López-Pérez, J.L.; Feliciano, A.S.; Fiebich, B.L.; Muñoz, E. Mesuol, a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-kappaB pathway. Antiviral Res., 2005, 66, 137-45.
48. Sancho, R.; de la Vega, L.; Macho, A.; Appendino, G.; Di Marzo, V.; Muñoz, E. Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine. J. Immunol., 2005, 175, 3990-9.
49. Mitsuhashi, S.; Kishimoto, T.; Uraki, Y.; Okamoto, T.; Ubukata, M. Low molecular weight lignin suppresses activation of NF-κB and HIV-1 promoter. Bioorg. Med. Chem., 2008, 16, 2645-50
50. Leban, J.; Baierl, M,; Mies, J.; Trentinaglia, V.; Rath, S.; Kronthaler, K.; Wolf, K.; Gotschlich, A.; Seifert, M.H. A novel class of potent NF-kappaB signaling inhibitors. Bioorg. Med. Chem. Lett., 2007, 17, 5858-62.
51. Bedoya, L.M.; del Olmo, E.; Sancho. R.; Barboza, B.; Beltrán, M.; García-Cadenas, A.E.; Sánchez-Palomino. S.; López-Pérez, J.L.; Muñoz, E.; San Feliciano, A.; Alcamí, J. Anti-HIV activity of stilbene-related heterocyclic compounds. Bioorg. Med. Chem. Lett., 2006, 16, 4075-9.